CAM
MRVI icon

Cresset Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Cresset Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-96,987
Closed -$806K – 2042
2024
Q3 		$806K Buy
96,987
+74,050
+323% +$640K ﹤0.01% 1272
2024
Q2 		$164K Buy
22,937
+975
+4% +$8.42K ﹤0.01% 1911
2024
Q1 		$190K Buy
21,962
+2,686
+14% +$18.2K ﹤0.01% 1782
2023
Q4 		$126K Buy
+19,276
New +$125K ﹤0.01% 1744

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cresset Asset Management's MRVI Position: Q4 2024 in Review

Cresset Asset Management sold out of Maravai LifeSciences (MRVI) in Q4 2024, closing a stake of 96,987 shares — an estimated $806K sold.

Cresset Asset Management first reported a position in MRVI in Q4 2023 and held it in 4 quarters. The position peaked at $806K in Q3 2024. 185 funds tracked by Wall St. Rank hold MRVI as of Q4 2024.

  • Cresset Asset Management reported no remaining Maravai LifeSciences position as of Q4 2024 after selling out during the quarter.
  • Cresset Asset Management sold 96,987 Maravai LifeSciences shares in Q4 2024, an estimated $806K.
  • Cresset Asset Management first reported a position in Maravai LifeSciences in Q4 2023 and held it in 4 quarters.
  • Cresset Asset Management's Maravai LifeSciences position peaked at $806K in Q3 2024.
  • 185 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2024.

Based on Cresset Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.